GLP-1 Primer for Cardiologists Wednesday, September 1, 2010 Yesterday, on my last day at the 2010 ESC meeting in Stockholm, I attended a session on incretins
Sold in packs of 10 vials
Many systematic reviews with network meta-analysis summarized the risk of noval hypoglycemic drugs on diabetic complications, including cardiovascular events, nonfatal stroke, renal composite outcomes and fatty liver (4245)
Mediterranean diet Cardiovasc health: Crit Rev
Baseline assessment should include current thyroid status with TSH, free T4, and free T3 levels, documentation of Graves disease treatment history and current management, assessment of thyroid eye disease or other complications, cardiovascular evaluation including heart rate and rhythm (as both hyperthyroidism and GLP-1 receptor agonists can affect heart rate), and standard metabolic parameters including HbA1c, lipid profile, and renal function